We are a biotechnology company committed to a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of heart disease.
Market Cap | 267.998 Million | Shares Outstanding | 41.294 Million | Avg 30-day Volume | 89.368 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -13.26 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -69.737 Million |
Price to Book Value | 2.8095 | Operating Margin | 0.0 | Enterprise Value | 531.222 Million |
Current Ratio | 11.728 | EPS Growth | 0.896 | Quick Ratio | 11.541 |
1 Yr BETA | 2.1055 | 52-week High/Low | 32.0 / 5.77 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -71.5575 | Altman Z-Score | 12.5994 | Free Cash Flow to Firm | -67.286 Million |
Earnings Report | 2022-08-15 |
Please sign in first
none
1.4 Thousand total shares from 1 transactions
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
HOEY TIMOTHY CHIEF SCIENTIFIC OFFICER |
|
198,646 | 2022-04-26 | 2 |
PATTERSON LEONE D CHIEF FIN. AND BUS. OFFICER |
|
66,000 | 2022-02-15 | 1 |
ALI FARAZ CHIEF EXECUTIVE OFFICER |
|
401,390 | 2022-02-15 | 1 |
TINGLEY WHITTEMORE CHIEF MEDICAL OFFICER |
|
141,000 | 2022-02-15 | 1 |
|
0 | 2021-12-22 | 2 | |
|
18,937 | 2021-11-22 | 2 | |
|
9,400,290 | 2021-08-03 | 1 | |
CASDIN PARTNERS MASTER FUND, L.P. |
|
3,586,818 | 2021-08-03 | 1 |
|
3,586,818 | 2021-08-03 | 1 | |
|
9,400,290 | 2021-08-03 | 1 | |
|
25,000 | 2021-08-03 | 1 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-04-28 19:57:56 -0400 | 2022-04-26 | S | 1,353 | $10.13 | d | 198,646 | direct | yes | 3.2538 | -21.1497 | 3.2538 | 2 | -21.1497 | 6 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 22:15:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 21:45:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 21:15:04 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 20:45:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 20:15:05 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 19:45:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 19:15:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 18:45:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 18:15:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 17:45:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 17:15:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 16:45:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 16:15:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 15:45:03 UTC | -3.1943 | 4.0143 | 500000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 15:15:03 UTC | -3.1943 | 4.0143 | 450000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 14:45:03 UTC | -3.0651 | 3.8851 | 450000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 14:15:04 UTC | -3.0651 | 3.8851 | 450000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 13:45:03 UTC | -3.0651 | 3.8851 | 450000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 13:15:03 UTC | -3.0651 | 3.8851 | 450000 |
TENAYA THERAPEUTICS INC TNYA | 2022-05-18 12:45:03 UTC | -3.0651 | 3.8851 | 450000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | TNYA | -600.0 shares, $-11370.0 | 2021-12-31 | N-PORT |
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund | TNYA | -389.0 shares, $-4636.88 | 2022-01-31 | N-PORT |